Skip to main content
. 2021 Nov 22;143(48):20224–20240. doi: 10.1021/jacs.1c08630

Figure 3.

Figure 3

Protocols used to determine the half-maximal inhibitory (IC50) concentrations of diazido-Pt(IV) complexes under dark (2 h drug exposure, protected from light) and photoactivated (1 h drug exposure, followed by 1 h irradiation with 465 nm light).